Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India

  • End date
    Mar 31, 2023
  • participants needed
  • sponsor
Updated on 21 August 2021
velaglucerase alfa


The purpose of this post-marketing survey study is to determine the safety and evaluate effectiveness in participants receiving VPRIV when used in the post-marketing setting and to collect and record genetic mutation data from participants with Gaucher disease.

Condition Gaucher Disease, gaucher's disease
Treatment Velaglucerase alfa (VPRIV)
Clinical Study IdentifierNCT04429984
Last Modified on21 August 2021


Yes No Not Sure

Inclusion Criteria

Participants prescribed VPRIV according to the investigator's judgment and current Indian PI are eligible for this study
Participants or legally authorized representative must provide written informed consent to participate

Exclusion Criteria

Participants will be excluded from this study if any of the contraindications included in the current Indian PI for VPRIV apply
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note